Other parenteral anticoagulants

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    This chapter reviews other parenteral anticoagulants–danaparoid which is a heparin like one and the direct thrombin inhibitors. Although heparin and its derivatives are the most commonly used parenteral anticoagulants, other agents are also used for this purpose. Since clinical trials showed most of these had no major advantages over heparin, use of most of these agents is restricted to patients with heparin induced thrombocytopenia. The exception is bivalirudin which is also used in patients with acute coronary syndromes undergoing interventions.

    Original languageEnglish (US)
    Title of host publicationHemostasis and Thrombosis, Third Edition
    PublisherSpringer International Publishing
    Pages117-119
    Number of pages3
    ISBN (Electronic)9783319093123
    ISBN (Print)9783319093116
    DOIs
    StatePublished - Jan 1 2015

    ASJC Scopus subject areas

    • Medicine(all)

    Fingerprint Dive into the research topics of 'Other parenteral anticoagulants'. Together they form a unique fingerprint.

  • Cite this

    DeLoughery, T. G. (2015). Other parenteral anticoagulants. In Hemostasis and Thrombosis, Third Edition (pp. 117-119). Springer International Publishing. https://doi.org/10.1007/978-3-319-09312-3_23